Assessment of IL-17A, IL-10 and TGF-beta1 serum titers in RRMS patients treated with Avonex, possible biomarkers for treatment response.

Bălaşa R, Maier S, Voidăzan S, Huţanu A, Bajkó Z, Moţăţăianu A, Tilea B, Tiu C

CNS Neurol Disord Drug Targets. 2016 Jun 15. PMID: 27306062. Abstract